Sort
50,496 grants matching “lung cancer”
Probing cytosolic nucleic acid sensing pathways in cancer
$704,556Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Probing cytosolic nucleic acid sensing pathways in cancer
$704,556Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
$704,509Orly Alter · University Of Utah · U01 · FY2017 · CA
Integrated analyses of genetics, epigenetics, and gene expression
$704,442Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2018 · CA
Characterizing the theranostic potential of DLL3-targeting agents in high-grade neuroendocrine carcinomas of the lung and prostate
$704,422Lisa Bodei · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Genetic and Epigenetic Biomarkers for SCC of the Lung
$704,377Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2010 · ES
Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States
$704,354Xuehong Zhang · Brigham And Women'S Hospital · U01 · FY2023 · CA
Artificial Lung Based on a Novel Microfluidic Technology
$704,352Anna M Galea · Vivonics, Inc. · R44 · FY2012 · HL
Novel Incidental Calcium Evaluation (NICE)
$704,276Fatima Rodriguez · Stanford University · R01 · FY2025 · HL
Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells
$704,266Kenji Yokoi · Methodist Hospital Research Institute · U01 · FY2021 · CA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care:I-CARE
$704,231Barry L Carter · University Of Iowa · R01 · FY2016 · HL
Genetic evolution of glioblastomas during radiation and temozolomide therapy
$704,210Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$704,064John Blenis · Harvard Medical School · R37 · FY2009 · CA
Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer
$703,909Kwok Kin Wong · New York University School Of Medicine · U01 · FY2017 · CA
(PQ1) HIV-infected T-cell exosomes in lung cancer progression
$703,784Ge Jin · Case Western Reserve University · R01 · FY2024 · CA
Clonal hematopoiesis, epigenetic changes, social determinants of health, and behavioral risk factors as predictors of accelerated aging in HIV
$703,644Inga Peter · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer
$703,616Faraz Bishehsari · Rush University Medical Center · R01 · FY2023 · CA
Imaging Activated Macrophages in the Lungs
$703,497Timothy S Blackwell · Vanderbilt University Medical Center · R01 · FY2017 · HL
Establishing the dynamics of lymphoid clonal hematopoiesis and its aging-related disease consequences
$703,426Alexander Bick · Vanderbilt University Medical Center · R01 · FY2024 · AG
Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer
$703,424Leopoldo Nicolas Segal · New York University School Of Medicine · U2C · FY2023 · CA
Targeting molecular mechanisms of the adeno-to-squamous transition in non-small cell lung cancer treatment adaptation
$703,410Itai Yanai · New York University School Of Medicine · R01 · FY2025 · CA
Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1
$703,389Jane Amanda Skok · New York University School Of Medicine · R01 · FY2025 · CA
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
$703,340William J Steinbach · Arkansas Children'S Hospital Res Inst · R01 · FY2022 · AI
Faith-Based Approaches in the Treatment of Hypertension (FAITH)
$703,322Gbenga Godwin Ogedegbe · New York University School Of Medicine · R01 · FY2012 · HL
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
$703,315William C Hahn · Dana-Farber Cancer Inst · U01 · FY2015 · CA